A Single-Center, Randomized, Double-Blind, Single and Multiple Doses, Placebo-Controlled Study,To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, Food Effects of HEC116094HCl3H2O and the Interaction With Oseltamivir Phosphate Capsules in Chinese Healthy Subjects
Latest Information Update: 14 Apr 2023
At a glance
- Drugs HEC 116094 (Primary) ; Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sunshine Lake Pharma
- 10 Apr 2023 Status changed from not yet recruiting to completed.
- 06 Aug 2021 New trial record